The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...

( NewsNation) — The FDA is eliminating “unnecessary testing” on animals, according to Commissioner Marty Makary. He joined “ ...

The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new ...

March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce animal studies of experimental drugs and adopt newer methods, such as computer ...

The guidance clarifies what sponsors should consider when putting together an application for the validation of a NAM ...

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...

Animal studies often fail to predict human tissue responses to new drugs or newly developed therapies. Besides generating tremendous costs for clinical studies, it also raises significant ethical ...

New draft guidance from the FDA is urging pharma companies to accelerate efforts to transition from animal testing to ...

Officials with the FDA have released a draft guidance that aims to help drug developers validate new approach methodologies (NAMs) that can be used in place of animal testing. Based on human-centric ...

The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as alternatives to animal testing in preclinical drug development. The guidance, ...

US FDA releases draft guidance on alternatives to animal testing in drug development: Silver Spring, Maryland Friday, March 20, 2026, 10:00 Hrs [IST] The US Food and Drug Administ ...

Criticism of animal research − usually associated with the progressive left − has grown in recent years, as the practice is blamed for the slow pace of drug development. The Food and Drug ...